285例冷冻卵巢组织移植:五家欧洲中心经验综述
本文综述五家欧洲中心共285例冷冻卵巢组织移植(OTT)的集体经验,聚焦手术技术、生殖结局、冻存前化疗影响、复发风险及内分泌恢复。结果显示再植入相关复发风险很低,几乎全部患者内分泌功能恢复,约四分之一获健康活产,但体外受精(IVF)效率不高,盆腔放疗可能显著降低妊娠可能。
要点
- 再植入卵巢组织相关复发风险很低
- 几乎全部移植者内分泌功能恢复,约四分之一获健康活产
- 盆腔放疗尤其较高剂量可能显著降低妊娠可能甚至禁忌
核心结论
- 冷冻卵巢组织移植在恢复生育力方面结果令人鼓舞并显示明确潜力,但方法远未成熟,需持续研究优化。
研究设计与样本
- 综述类:五家欧洲中心汇总285例冷冻卵巢组织移植女性的集体经验。
主要发现
- 根据当前数据,再植入卵巢组织所致复发风险似乎很低。
- 几乎全部接受卵巢组织移植的女性可见内分泌功能恢复。
- 约四分之一接受移植者获得健康活产。
- 该类患者IVF效率不高,需大幅改进。
- 盆腔放疗尤其相对较高剂量似乎显著降低成功妊娠可能性,并可能为禁忌。
关键数值与推荐
- 冻存前化疗不损害成功机会,取决于所给化疗的总剂量和类型。
- 再植入相关复发风险很低(据当前数据)。
- 几乎全部移植者内分泌功能恢复;约四分之一获健康活产。
- 盆腔放疗尤其相对较高剂量显著降低成功妊娠可能性并可能禁忌。
临床怎么用
- 向患者说明OTT可恢复内分泌功能且约四分之一获健康活产,但IVF效率有限。
- 评估冻存前化疗总剂量与类型,因其影响成功机会但不必然损害结局。
- 对有盆腔放疗史尤其较高剂量者,需谨慎评估OTT妊娠可能并考虑禁忌。
局限性
- OTT临床经验仍有限且开展速度较慢。
- 方法远未完全成熟,需持续研究优化。
- 该类患者IVF效率不高,需大幅改进。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The feasibility of freezing and thawing ovarian tissue is nowadays widely documented. However, ovarian tissue transplantation (OTT) is happening at a much slower pace, and clinical experience is somewhat limited. In this review, five European centers present their collective experience of transplanting ovarian tissue in 285 women. The focus is on surgical techniques and OTT outcomes, reproductive outcomes, the impact of chemotherapy before ovarian tissue cryopreservation (OTC), the risk of relapse, and endocrine resumption and longevity of transplanted tissue. The risk of relapse due to reimplantation of ovarian tissue appears to be very low according to current data. Recovery of endocrine function is seen in almost all women undergoing transplantation of ovarian tissue, and about one in four gives birth to a healthy child. The efficacy of in vitro fertilization in these patients is not very high, however, and needs to be substantially improved. Radiation to the pelvis, especially with relatively high doses, appears to considerably decrease the likelihood of a successful pregnancy and may be contraindicated. Our results demonstrate that chemotherapy before OTC does not impair the chances of success, depending, of course, on the total dose and type of chemotherapy administered. At this early stage of development of OTT for restoration of fertility, the results are encouraging and demonstrate clear potential. However, the method is far from being fully developed and requires continued research efforts to optimize our approach.
引用
- Dolmans MM, von Wolff M, Poirot C, et al. Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers. Fertil Steril. 2021. PMID: 33933173. doi:10.1016/j.fertnstert.2021.03.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。